Sales and Marketing

Showing 15 posts of 11527 posts found.

Hospira Reappoints chief scientific officer

May 15, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Hospira

Injectable drugs and infusion tech firm Hospira has announced that Sumant Ramachandra has been reappointed to his role as senior …

Pfizer targets Newcastle

May 15, 2013 Research and Development, Sales and Marketing ABPI, Cameron, NHS, Newcastle, Pfizer

Pfizer has earmarked Newcastle Hospitals NHS Foundation Trust as one of 60 sites worldwide to take part in a key …

Amgen and Zhejiang sign cancer deal

May 14, 2013 Sales and Marketing Amgen, Cancer, Zhejiang

Amgen has signed a joint venture deal with Chinese firm Zhejiang Beta Pharma to commercialise oncology drug Vectibix. The companies …

Optimer Pharmaceuticals appoints chief operating officer

May 14, 2013 Manufacturing and Production, Research and Development, Sales and Marketing

Biopharma firm Optimer Pharmaceuticals has announced the appointment of Eric Sirota as chief operating officer.  “Eric has tremendous experience and …

EMA ponders biosimilar guideline

May 14, 2013 Research and Development, Sales and Marketing EMA, biosimilars

The European Medicines Agency is thinking about changes to its guidance on similar biological medicines and has published a draft …

Lilly takes $30m hit

May 13, 2013 Research and Development, Sales and Marketing enzastaurin, lilly

Eli Lilly has taken a $30 million hit after abandoning late-stage development of its investigational cancer drug enzastaurin. The compound …

Francis at centre of Care Bill

May 13, 2013 Sales and Marketing Hunt, Mid Staffs, NHS

The government’s new Care Bill carries a variety of measures designed to ensure that failings such as those at the …

John LaMattina: India’s solution to drug costs

May 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, LaMattina, R&D

Drug pricing is a major issue in India. The Indian government believes that the prices of lifesaving drugs shouldn’t be …

New Board member for Misonix

May 13, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Misonix

Surgical device company Misonix has announced that Stavros Vizirgianakis has been appointed to its Board of directors.The addition of Vizirgianakis …

Takeda to buy Inviragen

May 10, 2013 Research and Development, Sales and Marketing Inviragen, Takeda

Takeda has hit the acquisition trail, putting together a $250 million package to buy private US biopharma firm Inviragen in …

Government confirms NHS ‘free’

May 10, 2013 Sales and Marketing Hunt, NHS, avaaz

The government has reaffirmed that NHS treatment “will remain free at the point of delivery and available according to clinical …

Egalet appoints Stan Musial as CFO

May 10, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Egalet, musial

Speciality pharma firm Egalet has announced the appointment of Stan Musial as chief financial officer.  Bob Radie, president and chief …

Dyadic International hires chief operating officer

May 10, 2013 Manufacturing and Production, Research and Development, Sales and Marketing dyadic

Biotech firm Dyadic International has appointed Danai Brooks to the role of executive VP and chief operating officer.  Starting in …

New Viagra site launched

May 10, 2013 Manufacturing and Production, Medical Communications, Sales and Marketing ED, Pfizer, viagra

Pfizer has launched a new sales website for Viagra, the ‘little blue pill’ which is its most counterfeited medicine, to …

VBP will be ‘unfair’: report

May 8, 2013 Medical Communications, Research and Development, Sales and Marketing 2020health, ABPI, NHS, VBP

A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …
The Gateway to Local Adoption Series

Latest content